Race Oncology Investor Briefing – Melbourne 20th Oct 2022

02 Nov
Nov , 02 , 2022 Daniel Tillett
LinkedIn

Related posts:

September 2022 Quarterly Activity Report & Appendix 4C Pitt Street Research Initiates Coverage of Race Oncology Zantrene Protects Mouse Hearts from Chemotherapy Damage